The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status

The International Duration Evaluation of Adjuvant Chemotherapy (IDEA) collaboration was established to prospectively combine and analyze data from several randomized trials conducted around the world to answer whether a three-month course of oxaliplatin-based adjuvant therapy (FOLFOX4/modified FOLFO...

Descripción completa

Detalles Bibliográficos
Autores principales: André, Thierry, Iveson, Timothy, Labianca, Roberto, Meyerhardt, Jeffrey A., Souglakos, Ioannis, Yoshino, Takayuki, Paul, James, Sobrero, Alberto, Taieb, Julien, Shields, Anthony F., Ohtsu, Atsushi, Grothey, Axel, Sargent, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Adjuvant Therapy for Colon Cancers (AB Benson III and A de Gramont, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766516/
https://www.ncbi.nlm.nih.gov/pubmed/24032000
http://dx.doi.org/10.1007/s11888-013-0181-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766516/
https://www.ncbi.nlm.nih.gov/pubmed/24032000
http://dx.doi.org/10.1007/s11888-013-0181-6

Ejemplares similares